On September 19, under the guidance of the Guangzhou Municipal Bureau of Science and Technology, the 11th China Innovation and Entrepreneurship Competition (Guangdong · Guangzhou Competition Area) and the final of the 2022 Guangzhou Science and Technology Innovation and Entrepreneurship Competition/Biomedical Industry Competition were successfully held. As a national innovation and entrepreneurship event, The China Innovation and Entrepreneurship Competition is the oldest and most influential innovation and entrepreneurship event in China.
![236215895d13c5ff_html_898b442c2c84ac60](https://wds-service-1258344699.file.myqcloud.com/20/13954/jpg/16669214574801d67a2e506665f53.jpg?version=1666921773)
This year, 89 biopharmaceutical enterprises took part in fierce competition, including 19 enterprises in the final round of the start-up group for final PK, and 70 enterprises in the semi-final of the growth group for tickets to the final. An "8+2" road show mode was adopted for the final round of the start-up group. In this mode, the participating enterprises conducted an 8-minute self-statement and a 2-minute defense. Following the principles of "openness, fairness, impartiality and competitive excellence", the participating enterprises were judged on five aspects, namely; technology and products, business model and implementation plan, industry and market, financial analysis, and team.
As one of the competitors in the start-up group, RecoRNA’s project of "disease treatment based on RNA editing technology" overcame all challenges and won second place! This competition marks the first time that RecoRNA has participated in a National mass entrepreneurship and innovation competition.
Results Announcement
![第一篇的](https://wds-service-1258344699.file.myqcloud.com/20/13954/jpg/1666259220888b683e47b0616c6d9.jpg?version=0)